Ministers urged to open up access to magic mushroom compound psilocybin for mental health researchers
by Daniel Keane
Dec 27, 2023
2 minutes
Ministers have been urged to open up access for scientists to psilocybin, the chemical compound in magic mushrooms, to allow research into its potential therapeutic benefits.
Psilocybin, a Class A drug and a psychedelic, is currently being trialled as an including depression, anorexia and addiction.
You’re reading a preview, subscribe to read more.
Start your free 30 days